Advertisement
Screener

Axogen, Inc. (AXGN) Gain (Loss) on Derivative Instruments, Net, Pretax

2.8 / 5 stars · 68/120 Roast Me

Axogen, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax

Axogen, Inc. (AXGN) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$28.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2022-02-25

  • Axogen, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2021 was -$28.00K.
  • Axogen, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2020 was -$117.00K.
  • Axogen, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2019 was $0.00.
  • Axogen, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2018 was $0.00.
Period endGain (Loss) on Derivative Instruments, Net, Pretax 12 month
2021-12-31-$28.00K
10-K · filed 2022-02-25
2020-12-31-$117.00K
10-K · filed 2022-02-25
2019-12-31$0.00
10-K · filed 2022-02-25
2018-12-31$0.00
10-K · filed 2021-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53